DPYSL2 and Alzheimer disease: Tukey’s post hoc tests indicated that the phosphorylation of CRMP2 at Thr514 in the prefrontal cortex was significantly up-regulated in the 3 × Tg-AD control group compared to the non-Tg control group (p < 0.001; Figure 4E).